Sponsored Research and Clinical Trial Agreements - summary of Helocyte's expense related to its clinical research arrangements (Detail) - Helocyte Inc [Member] - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
Payments For Research And Development Expenses | $ 113 | $ 1,639 | $ 317 | $ 2,920 |
COH Triplex Clinical Research and Support [Member] | ||||
Payments For Research And Development Expenses | 0 | 1,300 | 0 | 2,335 |
COH PepVax Clinical Research And Support [Member] | ||||
Payments For Research And Development Expenses | 0 | 327 | 0 | 561 |
COH Pentamer clinical research and support [Member] | ||||
Payments For Research And Development Expenses | $ 113 | $ 12 | $ 317 | $ 24 |
X | ||||||||||
- Definition The amount of cash outflow associated research and development expenses paid during the period. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|